Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Harrison

Showing results (561-570 of 584) with videos related to

Pageof 59
Sort By:
The New England Journal of Medicine|April 5, 2018
Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant EffusionRahul Bhatnagar, Emma K Keenan, Anna J Morley, et al.
Leukemia|July 18, 2013
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) studyJ V Jovanovic, A Ivey, A M Vannucchi, et al.
Blood|January 10, 2022
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemiaJohn Mascarenhas, Heidi E Kosiorek, Josef T Prchal, et al.
Leukemia|March 13, 2025
Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia veraYan Beauverd, Jean-Christophe Ianotto, Kyaw Htin Thaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNsRobyn M Emanuel, Amylou C Dueck, Holly L Geyer, et al.
Blood Advances|July 8, 2022
Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needsMarta Sobas, Jean-Jacques Kiladjian, Yan Beauverd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2015
Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled DiseaseHolly Geyer, Robyn Scherber, Heidi Kosiorek, et al.
Blood|March 19, 2025
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMTNicola Polverelli, Juan Carlos Hernandez-Boluda, Francesco Onida, et al.
JAMA|December 6, 2019
Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical TrialRahul Bhatnagar, Hania E G Piotrowska, Magda Laskawiec-Szkonter, et al.
Haematologica|August 20, 2016
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working GroupHolly L Geyer, Heidi Kosiorek, Amylou C Dueck, et al.
Pageof 59

Showing results (561-570 of 584) with videos related to

Sort By:
Pageof 59
The New England Journal of Medicine|April 5, 2018
Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant EffusionRahul Bhatnagar, Emma K Keenan, Anna J Morley, et al.
Leukemia|July 18, 2013
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) studyJ V Jovanovic, A Ivey, A M Vannucchi, et al.
Blood|January 10, 2022
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemiaJohn Mascarenhas, Heidi E Kosiorek, Josef T Prchal, et al.
Leukemia|March 13, 2025
Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia veraYan Beauverd, Jean-Christophe Ianotto, Kyaw Htin Thaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNsRobyn M Emanuel, Amylou C Dueck, Holly L Geyer, et al.
Blood Advances|July 8, 2022
Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needsMarta Sobas, Jean-Jacques Kiladjian, Yan Beauverd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2015
Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled DiseaseHolly Geyer, Robyn Scherber, Heidi Kosiorek, et al.
Blood|March 19, 2025
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMTNicola Polverelli, Juan Carlos Hernandez-Boluda, Francesco Onida, et al.
JAMA|December 6, 2019
Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical TrialRahul Bhatnagar, Hania E G Piotrowska, Magda Laskawiec-Szkonter, et al.
Haematologica|August 20, 2016
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working GroupHolly L Geyer, Heidi Kosiorek, Amylou C Dueck, et al.
Pageof 59